CGEM - Wall Street Estimates - Cullinan Oncology, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 9.08

4.73 %

$ 531 M

Market Cap

-3.27

P/E

Price Target Average

241.41%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

29.85%

Net Income Estimate

8.40%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Cullinan Oncology, Inc.

Wall Street analysts predict an average 1-year price target for CGEM of $31 , with forecasts ranging from a low of $28 to a high of $38 .

CGEM Lowest Price Target Wall Street Target

28 USD 208.37%

CGEM Average Price Target Wall Street Target

31 USD 241.41%

CGEM Highest Price Target Wall Street Target

38 USD 318.50%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free